• 52,754+ CME Conference Registrations Sold
  • 158,262+ Medical Conferences
  • 285 Specialties
  • 11,425 Organizers
  • 157,177 Speakers
  • 159 Countries
  • 4,803 Cities

Molecular Tumor Board: Colon Adenocarcinoma, Endometrial Adenocarcinoma and Breast Invasive Ductal Carcinoam (IDC) is organized by Cancer Treatment Centers of America® (CTCA).

Released: February 22, 2019
Expires: February 22, 2020

Intended Audience:
Physicians or other clinicians who particpate in molecular tumor boards.

Maximum Credits:
0.75 / AMA PRA Category 1 Credit.

Description:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma, and breast invasive ductal carcinoma (IDC).

Educational Objectives:
Upon completion of this activity, participants will be able to:
• Utilize skills learned in this activity to implement an effective molecular tumor board
• Describe genomic testing and when it is appropriate to test
• Implement genomic profiling into oncology treatment and select the appropriate patient that is an ideal candidate for profiling

Intended Audience

Genetics, Oncology

Activity Payment Details

Activity Fee : NA
Interested

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

Cancer Treatment Centers of America® (CTCA)

View Organizer Details

Help

770 400 6031

Convert
Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended